Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones

Purpose To identify clinical and non-clinical predictors of treatment failure and perioperative complications following ureterorenoscopy versus shockwave lithotripsy. Methods The New York State Department of Health Statewide Planning and Research Cooperative System (SPARCS) database was used to iden...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of urology 2021-06, Vol.39 (6), p.2177-2182
Hauptverfasser: Friedlander, David F., Brant, Aaron, McClure, Timothy D., Del Pizzo, Joseph, Nowels, Molly A., Trinh, Quoc-Dien, Sedrakyan, Art, Chughtai, Bilal
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2182
container_issue 6
container_start_page 2177
container_title World journal of urology
container_volume 39
creator Friedlander, David F.
Brant, Aaron
McClure, Timothy D.
Del Pizzo, Joseph
Nowels, Molly A.
Trinh, Quoc-Dien
Sedrakyan, Art
Chughtai, Bilal
description Purpose To identify clinical and non-clinical predictors of treatment failure and perioperative complications following ureterorenoscopy versus shockwave lithotripsy. Methods The New York State Department of Health Statewide Planning and Research Cooperative System (SPARCS) database was used to identify 226,331 patients who underwent index ureteroscopy or shockwave lithotripsy for renal stones from 2000 to 2016. Propensity-matched generalized linear-mixed modeling was utilized to compare failure and complication rates between the two procedure groups. Results 219,383 individuals meeting inclusion criteria who underwent either ureterorenoscopy ( n  = 124,342) or shockwave lithotripsy ( n  = 95,041) in New York State between 2000 and 2016 were included in our analysis. After propensity score matching, patients undergoing shockwave lithotripsy were found to have decreased odds of experiencing any type of 30-day complication ( P  
doi_str_mv 10.1007/s00345-020-03430-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2441614062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2543582786</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-d5d8732a459c1eed32025084bee29e2eeb0cfe143adc2a59cf04678b52fcacfc3</originalsourceid><addsrcrecordid>eNp9kU9rFEEQxRsx4Jr4BTw1ePHSWtN_ZmaPEjQGAoLouentqXYnzk6PVT0J--3tdQOCB09VUL_3qMcT4nUD7xqA7j0DGOsUaFB1MaDaZ2LTWGNU3-n2udhAp62y2968EC-Z7wGargW3EcevGCb1mGkaZMyHJVAo4wNKTAnjaZuRWeYkeZ_jz8dQT9NY9rnQuPBRPiDxynIlLEiZcM4c83KUKZMse5SFMJQDzuVksdI4BzpKLrm6XomLFCbGV0_zUnz_9PHb9Wd19-Xm9vrDnYrG6aIGN_Sd0cG6bWwQB6NBO-jtDlFvUSPuICasUcMQdahQAtt2_c7pFENM0VyKt2ffhfKvFbn4w8gRpynMmFf22tqmbSy0uqJv_kHv80pz_c5rZ43rdde3ldJnKlJmJkx-ofFQg_kG_KkNf27D1zb8nzb8SWTOIq7w_APpr_V_VL8BA-iRCw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2543582786</pqid></control><display><type>article</type><title>Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones</title><source>SpringerLink Journals</source><creator>Friedlander, David F. ; Brant, Aaron ; McClure, Timothy D. ; Del Pizzo, Joseph ; Nowels, Molly A. ; Trinh, Quoc-Dien ; Sedrakyan, Art ; Chughtai, Bilal</creator><creatorcontrib>Friedlander, David F. ; Brant, Aaron ; McClure, Timothy D. ; Del Pizzo, Joseph ; Nowels, Molly A. ; Trinh, Quoc-Dien ; Sedrakyan, Art ; Chughtai, Bilal</creatorcontrib><description>Purpose To identify clinical and non-clinical predictors of treatment failure and perioperative complications following ureterorenoscopy versus shockwave lithotripsy. Methods The New York State Department of Health Statewide Planning and Research Cooperative System (SPARCS) database was used to identify 226,331 patients who underwent index ureteroscopy or shockwave lithotripsy for renal stones from 2000 to 2016. Propensity-matched generalized linear-mixed modeling was utilized to compare failure and complication rates between the two procedure groups. Results 219,383 individuals meeting inclusion criteria who underwent either ureterorenoscopy ( n  = 124,342) or shockwave lithotripsy ( n  = 95,041) in New York State between 2000 and 2016 were included in our analysis. After propensity score matching, patients undergoing shockwave lithotripsy were found to have decreased odds of experiencing any type of 30-day complication ( P  &lt; 0.001 for all) but increased odds of treatment failure at both 90 (OR 1.70, 95% CI 1.64–1.77) and 180 (OR 1.83, 95% CI 1.76–1.89) days ( P  &lt; 0.001 for both). Conclusion Patients undergoing shockwave lithotripsy experienced significantly higher odds of treatment failure, although this undesirable outcome appears to be partially offset by lower 30-day complication rates.</description><identifier>ISSN: 0724-4983</identifier><identifier>EISSN: 1433-8726</identifier><identifier>DOI: 10.1007/s00345-020-03430-6</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Lithotripsy ; Medicine ; Medicine &amp; Public Health ; Nephrolithiasis ; Nephrology ; Oncology ; Original Article ; Patients ; Urology</subject><ispartof>World journal of urology, 2021-06, Vol.39 (6), p.2177-2182</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-d5d8732a459c1eed32025084bee29e2eeb0cfe143adc2a59cf04678b52fcacfc3</citedby><cites>FETCH-LOGICAL-c352t-d5d8732a459c1eed32025084bee29e2eeb0cfe143adc2a59cf04678b52fcacfc3</cites><orcidid>0000-0002-0515-2578</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00345-020-03430-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00345-020-03430-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Friedlander, David F.</creatorcontrib><creatorcontrib>Brant, Aaron</creatorcontrib><creatorcontrib>McClure, Timothy D.</creatorcontrib><creatorcontrib>Del Pizzo, Joseph</creatorcontrib><creatorcontrib>Nowels, Molly A.</creatorcontrib><creatorcontrib>Trinh, Quoc-Dien</creatorcontrib><creatorcontrib>Sedrakyan, Art</creatorcontrib><creatorcontrib>Chughtai, Bilal</creatorcontrib><title>Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones</title><title>World journal of urology</title><addtitle>World J Urol</addtitle><description>Purpose To identify clinical and non-clinical predictors of treatment failure and perioperative complications following ureterorenoscopy versus shockwave lithotripsy. Methods The New York State Department of Health Statewide Planning and Research Cooperative System (SPARCS) database was used to identify 226,331 patients who underwent index ureteroscopy or shockwave lithotripsy for renal stones from 2000 to 2016. Propensity-matched generalized linear-mixed modeling was utilized to compare failure and complication rates between the two procedure groups. Results 219,383 individuals meeting inclusion criteria who underwent either ureterorenoscopy ( n  = 124,342) or shockwave lithotripsy ( n  = 95,041) in New York State between 2000 and 2016 were included in our analysis. After propensity score matching, patients undergoing shockwave lithotripsy were found to have decreased odds of experiencing any type of 30-day complication ( P  &lt; 0.001 for all) but increased odds of treatment failure at both 90 (OR 1.70, 95% CI 1.64–1.77) and 180 (OR 1.83, 95% CI 1.76–1.89) days ( P  &lt; 0.001 for both). Conclusion Patients undergoing shockwave lithotripsy experienced significantly higher odds of treatment failure, although this undesirable outcome appears to be partially offset by lower 30-day complication rates.</description><subject>Lithotripsy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Nephrolithiasis</subject><subject>Nephrology</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Patients</subject><subject>Urology</subject><issn>0724-4983</issn><issn>1433-8726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kU9rFEEQxRsx4Jr4BTw1ePHSWtN_ZmaPEjQGAoLouentqXYnzk6PVT0J--3tdQOCB09VUL_3qMcT4nUD7xqA7j0DGOsUaFB1MaDaZ2LTWGNU3-n2udhAp62y2968EC-Z7wGargW3EcevGCb1mGkaZMyHJVAo4wNKTAnjaZuRWeYkeZ_jz8dQT9NY9rnQuPBRPiDxynIlLEiZcM4c83KUKZMse5SFMJQDzuVksdI4BzpKLrm6XomLFCbGV0_zUnz_9PHb9Wd19-Xm9vrDnYrG6aIGN_Sd0cG6bWwQB6NBO-jtDlFvUSPuICasUcMQdahQAtt2_c7pFENM0VyKt2ffhfKvFbn4w8gRpynMmFf22tqmbSy0uqJv_kHv80pz_c5rZ43rdde3ldJnKlJmJkx-ofFQg_kG_KkNf27D1zb8nzb8SWTOIq7w_APpr_V_VL8BA-iRCw</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Friedlander, David F.</creator><creator>Brant, Aaron</creator><creator>McClure, Timothy D.</creator><creator>Del Pizzo, Joseph</creator><creator>Nowels, Molly A.</creator><creator>Trinh, Quoc-Dien</creator><creator>Sedrakyan, Art</creator><creator>Chughtai, Bilal</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0515-2578</orcidid></search><sort><creationdate>20210601</creationdate><title>Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones</title><author>Friedlander, David F. ; Brant, Aaron ; McClure, Timothy D. ; Del Pizzo, Joseph ; Nowels, Molly A. ; Trinh, Quoc-Dien ; Sedrakyan, Art ; Chughtai, Bilal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-d5d8732a459c1eed32025084bee29e2eeb0cfe143adc2a59cf04678b52fcacfc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Lithotripsy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Nephrolithiasis</topic><topic>Nephrology</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Patients</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Friedlander, David F.</creatorcontrib><creatorcontrib>Brant, Aaron</creatorcontrib><creatorcontrib>McClure, Timothy D.</creatorcontrib><creatorcontrib>Del Pizzo, Joseph</creatorcontrib><creatorcontrib>Nowels, Molly A.</creatorcontrib><creatorcontrib>Trinh, Quoc-Dien</creatorcontrib><creatorcontrib>Sedrakyan, Art</creatorcontrib><creatorcontrib>Chughtai, Bilal</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Friedlander, David F.</au><au>Brant, Aaron</au><au>McClure, Timothy D.</au><au>Del Pizzo, Joseph</au><au>Nowels, Molly A.</au><au>Trinh, Quoc-Dien</au><au>Sedrakyan, Art</au><au>Chughtai, Bilal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones</atitle><jtitle>World journal of urology</jtitle><stitle>World J Urol</stitle><date>2021-06-01</date><risdate>2021</risdate><volume>39</volume><issue>6</issue><spage>2177</spage><epage>2182</epage><pages>2177-2182</pages><issn>0724-4983</issn><eissn>1433-8726</eissn><abstract>Purpose To identify clinical and non-clinical predictors of treatment failure and perioperative complications following ureterorenoscopy versus shockwave lithotripsy. Methods The New York State Department of Health Statewide Planning and Research Cooperative System (SPARCS) database was used to identify 226,331 patients who underwent index ureteroscopy or shockwave lithotripsy for renal stones from 2000 to 2016. Propensity-matched generalized linear-mixed modeling was utilized to compare failure and complication rates between the two procedure groups. Results 219,383 individuals meeting inclusion criteria who underwent either ureterorenoscopy ( n  = 124,342) or shockwave lithotripsy ( n  = 95,041) in New York State between 2000 and 2016 were included in our analysis. After propensity score matching, patients undergoing shockwave lithotripsy were found to have decreased odds of experiencing any type of 30-day complication ( P  &lt; 0.001 for all) but increased odds of treatment failure at both 90 (OR 1.70, 95% CI 1.64–1.77) and 180 (OR 1.83, 95% CI 1.76–1.89) days ( P  &lt; 0.001 for both). Conclusion Patients undergoing shockwave lithotripsy experienced significantly higher odds of treatment failure, although this undesirable outcome appears to be partially offset by lower 30-day complication rates.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s00345-020-03430-6</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0515-2578</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0724-4983
ispartof World journal of urology, 2021-06, Vol.39 (6), p.2177-2182
issn 0724-4983
1433-8726
language eng
recordid cdi_proquest_miscellaneous_2441614062
source SpringerLink Journals
subjects Lithotripsy
Medicine
Medicine & Public Health
Nephrolithiasis
Nephrology
Oncology
Original Article
Patients
Urology
title Real-world comparative effectiveness of shockwave lithotripsy versus ureterorenoscopy for the treatment of urinary stones
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T22%3A38%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Real-world%20comparative%20effectiveness%20of%20shockwave%20lithotripsy%20versus%20ureterorenoscopy%20for%20the%20treatment%20of%20urinary%20stones&rft.jtitle=World%20journal%20of%20urology&rft.au=Friedlander,%20David%20F.&rft.date=2021-06-01&rft.volume=39&rft.issue=6&rft.spage=2177&rft.epage=2182&rft.pages=2177-2182&rft.issn=0724-4983&rft.eissn=1433-8726&rft_id=info:doi/10.1007/s00345-020-03430-6&rft_dat=%3Cproquest_cross%3E2543582786%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2543582786&rft_id=info:pmid/&rfr_iscdi=true